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I
nnate-like lymphocytes natural killer (NK) T cells, ␥␦ T cells, marginal zone (MZ) B cells, and B1-B cells are important for early immune defense against viruses, bacteria, and tumors (1) . They share common traits, such as germ-line transcript-encoded receptors with limited repertoires and low activation threshold. Activation of one of these cell types, invariant NK (iNK) T cells, has been most thoroughly evaluated after stimulation with ␣Galacto-sylCeramide (␣GalCer), a synthetic mimic of a natural glycolipid that evokes rapid production of large amounts of cytokines, particularly IL-4 and IFN-␥ (2), when presented by CD1d. CD1d-restricted iNK T cells are important in defense against bacterial, viral, and parasitic infections (3) (4) (5) , and specifically react to purified bacterial lipid antigens such as Borellia burgdorferi diacylglycerol (BbGL-II) (6) and Sphingomonas species glycolipids (7) . Once stimulated, iNK T cells activate many other cell types, including NK cells, dendritic cells (DCs), T cells, and B cells (8) .
Murine iNK T cell activation in vivo with ␣GalCer induces IL-4-dependent expression of activation markers CD69, B7-2, and I-A b on B cells (9) , and human NK T cell activation in vitro with ␣GalCer induces IL-4/IL-13-dependent B cell proliferation and total IgM, IgG1 antibody production (10) . Reduced antibody responses in CD1d Ϫ/Ϫ or J␣18 Ϫ/Ϫ mice compared with WT mice during infection or autoimmune disease (3) (4) (5) 11 ) is also consistent with iNK T cells and B cell cooperation. Naturally occurring IgG antilipid antibodies have been detected during malaria infection (12) , systemic lupus erythematosus (13) , and diabetes (14) , implying that lipid-specific B cells received T cell help for class switching in these models. Antibody production by protein-specific B cells is most efficient when the B cell receives cognate T cell help from T cells specific for peptides contained within the same protein internalized through the BcR (15) , so in analogy to MHC II-restricted responses, class switched antilipid responses may depend on lipidspecific T cells. Vaccine studies show that murine MHC IIrestricted anti-protein IgG1 and IgA responses are improved by in vivo coadministration of ␣GalCer (16) and have shown a requirement for CD1d on B cells (17) , but direct, cognate help from CD1d-restricted lipid-specific T cells for a lipid-specific B cell has not been described.
Here, we use haptenated model lipid antigens to understand iNK T cell antilipid help for lipid specific B cells, mimicking the approach used to characterize CD4 ϩ T cell help for protein-specific B cells (18) . We demonstrate cognate CD1d-restricted iNK T cell help for B cell proliferation and antibody production against the model haptened-lipid antigen. In this system, B cells responding to the hapten, 4-hydroxy-3-nitrophenyl (NP), are recognizing a component of the lipid antigen and mimic lipid-specific B cells. By definition, T cells do not recognize haptens, they only provide help if they recognize a component of a larger molecule conjugated to the hapten. Here that larger molecule is the lipid antigen, ␣GalCer. These results provide insights into the source of help driving lipid-specific antibody production with relevance for defense against microbial infections and vaccine protection.
Results
Synthesis and Biologic Activity of Haptenated-Lipid Antigens. We have synthesized hybrid haptenated lipids that contain a B cell recognition component, a hapten, and an iNK T cell recognition component, a glycolipid. The lipid components of these molecules include the well described iNK T cell agonist, ␣GalCer, or as a control, the closely related, but weak agonist, ␤-GalactosylCeramide (␤GalCer). The structure of each molecule contains a hapten, nitrophenyl, conjugated by way of a six-carbon linker attached at C2 of the galactose [supporting information (SI) Fig. S1 ]. The sphingosine base is attached to the sugar ring, either in the ␣ anomeric linkage in the active molecule (NP-␣GalCer) or the ␤ anomeric linkage in the control structure (NP-␤GalCer) (Fig. 1A) .
Initial in vitro studies compared the iNK T cell stimulating activity of the synthetic, haptenated antigens with the unmodified lipids. NP-␣GalCer-or ␣GalCer-loaded, plate-bound mouse CD1d fusion protein stimulated two iNK T cell hybridomas, DN32D3 (Fig. 1B ) and 24.9E (Fig. S2) , to produce significantly (P Յ 0.05) more IL-2 than media or NP-linked ␤GalCer. No antigen-presenting cells (APCs) are involved in this assay, eliminating any presentation advantage from receptor cross-linking or uptake. NP-␣GalCer also activates iNK T cells in vivo. CD69 expression on NK T cells was higher after i.p. ␣CD3 [mean fluorescence intensity (MFI) 611], ␣GalCer (MFI 1539), and NP-␣GalCer (MFI 1023) than after PBS (MFI 522) (Fig. 1C) . Both in vivo and in vitro experiments confirm that NP hapten modification of ␣GalCer or ␤-GalCer does not alter their recognition by iNK T cells.
NP-␣GalCer Stimulates T Cell Help-Dependent Antibody Responses.
NP-␣GalCer was next examined for immunogenicity by assessing antibody responses in vivo. Immunization with NP-␣GalCer in PBS, but not negative controls [NP-keyhole limpet hemocyanin (KLH), NP-␤GalCer, or PBS/BSA], stimulated both IgM (17 g/ml IgM vs. 3 g/ml with PBS on day 7; data not shown) and IgG anti-4-hydroxy-3-iodo-5-nitrophenylacetate (NIP) (212 g/ml IgG vs. 14 g/ml IgG with PBS on day 7) (Fig. 2A) in a dose-dependent fashion (Fig. S3A) . The NP-␣GalCer response is not bystander activation because immunization with ␣GalCer alone does not induce IgM or IgG anti-NIP (4 g/ml IgG) above PBS/BSA (14 g/ml IgG on day 7) (Fig. 2 A and IgM; data not shown), nor does ␣GalCer or NP-␣GalCer change total IgG titers (data not shown). NP-␣GalCer immunogenicity was confirmed in vitro by using a mixed culture of NP-specific B1-8 hi (19) splenic B cells and iNK T cell receptor transgenic (20) splenic T cells (iNKT TcR Tg T cells). By day 7, NP-␣GalCer stimulated 3.2 g/ml anti-NIP IgG, whereas ␣GalCer, NP-KLH, NP-␤GalCer, and media stimulated Ͻ0.05 g/ml IgG anti-NIP (Fig. 2B ). FACS analysis of in vitro cultures confirms the specificity of these cells' proliferation: LPS stimulates B cell (31%) but not T cell proliferation (2%), and ␣CD3 stimulates T cell (52%) but not B cell proliferation (8%) (Fig. S3B) . NP-␣GalCer (10 ng/ml) stimulates such robust proliferation from both B cells (29%) and T cells (29%), that the response is still evident at a 100-fold lower concentration of NP-␣GalCer, 0.1 ng/ml (34% B cells, 17% T cells) (Fig. S3C) . In comparison, NP-␤GalCer stimulates moderate B cell (24%) and little T cell proliferation (5%) at a high dose of 10 ng/ml, and no proliferation (1% B cells and Ͻ1% T cells) at a lower dose of 0.1 ng/ml, suggesting high-dose NP-␤GalCer may cross-link the BcR, but is not sufficiently recognized to be stimulatory to T cells. Thus, immunization with NP-␣GalCer stimulates rapid, dosedependent IgM and IgG anti-NIP, and T and B cell proliferation, consistent with NP-␣GalCer-specific iNK T cell help for haptenspecific B cells. ϩ iNK T cells (B6 J␣18 Ϫ/Ϫ ), or WT B6 controls were immunized with NP-␣GalCer. Only WT B6 mice made significant IgG (17 g/ml) and IgM (89 g/ml) anti-NP-␣GalCer by day 6 (Fig. 3) . No mice made any specific anti-NIP IgG or IgM by day 6 when immunized with controls ␣GalCer (Ͻ1 g/ml) or PBS (Ͻ1 g/ml) (data not shown). This finding confirms the requirement for CD1d/NP-␣GalCer recognition by iNK T cells to facilitate specific anti-NIP antibody production. Human CD4 ϩ NK T cell clones are better in vitro inducers of total B cell IgG than CD4 Ϫ CD8 Ϫ NK T cell clones (10), so mice lacking CD4 (CD4 Ϫ/Ϫ ) were examined to evaluate whether CD4 expression on murine NK T cells is similarly required. Seven days after NP-␣GalCer immunization, substantial IgG anti-NIP was detectable in both the B6 WT (146 g/ml) and CD4 Ϫ/Ϫ mice (147 g/ml) despite the fact that CD4 Ϫ/Ϫ mice had a reduced IgG anti-NIP response to NP-KLH/alum (below detection) compared with B6 WT mice (22 g/ml IgG) (Fig. S4A) . Thus, CD4 expression is required for peptide-specific, but not lipid-specific, T cell help in this system.
The importance of CD1d for a response to NP-␣GalCer by B and T cells was confirmed by using CD1d-blocking antibodies in vitro. Flow cytometry of mixed, carboxyfluorescein succinimidyl ester (CFSE)-labeled, in vitro cultured B1-8 hi B and iNK TcR Tg T cells reveals that anti-CD1d blocking antibody reduces T cell proliferation in response to NP-␣GalCer from 24% to 5% and B cell proliferation from 23% to 14% (Fig. S4B) . Only 3-5% of the B cells in these cultures are specific for NP (19) , so not all B cells will respond or be affected by T helper cells. The reduction in B cell proliferation after CD1d blocking provides further evidence that iNK T cells are contributing to B cell proliferation in this system.
iNK T Cell Help for B cells Involves Cognate B-T Interactions.
T cell help stimulates B cell proliferation, antibody production, or class switch most efficiently if provided by a T cell recognizing its cognate antigen presented by the B cell. To determine whether iNK T cells are capable of providing efficient, specific, cognate T cell help we compared immunization of mice with an NP-linked lipid (NP␤GalCer) or protein (NP-KLH) antigen plus ␣GalCer. Mixed together, the NP B cell antigen and the ␣GalCer iNK T antigen should end up in the same cells, leading to cognate help. Contrarily, immunizing mice with T and B cell antigens in disparate locations increases the chance that the antigens will be taken up by different APCs, allowing only noncognate help. We found that day-9 IgG anti-NIP titers were comparable in mice separately immunized with NP-KLH and ␣GalCer (25 g/ml) or NP-KLH mixed with ␣GalCer (21 g/ml) (Fig. 4A) . However, mice produced lower IgG anti-NIP when immunized separately with NP-␤GalCer and ␣GalCer (below detection) compared with mixed NP-␤GalCer and ␣GalCer (25 g/ml) (Fig. 4B) .
␣GalCer alone does not induce nonspecific IgG anti-NIP, and immunization with NP-KLH or NP-␤GalCer in the absence of adjuvant or an iNK T cell ligand does not induce IgG anti-NIP either (Fig. S5) . Further, NP-␤GalCer mixed with ␣GalCer and NP-KLH mixed with ␣GalCer give equivalent IgG anti-NIP responses (25 and 21 g/ml, respectively) ( Fig. 4 A and B) to those (Fig. 5) . Further studies will detail the relationship between these two populations.
To gain additional insight into which B cell subpopulations are activated, we measured the antibody isotypes produced in response to NP-␣GalCer immunization. Typically, class switch to IgG2a/c and IgG3 is facilitated by IFN-␥, whereas IgG1 and IgG2b are facilitated by IL-4 and TGF-␤, respectively (21) . B6 WT mice immunized with NP-␣GalCer produce more IgM (1:110,000 titer), IgG2c (1:101,250 titer), and IgG3 (1:31,250 titer) anti-NIP than IgG1 (1:9,538 titer) or IgG2b (1:8,000 titer) anti-NIP (Fig. 6A) , typical of a predominant influence from IFN-␥. In comparison, immunization with NP-KLH ϩ alum induces a profile more typical of an IL-4-driven response with dominant IgG1 (1:3,500 titer) and IgG2b (1:3,833 titer) (Fig. 6B) . At the same time, it is evident that immunization with NP-␤GalCer plus ␣GalCer (mixed, i.p.) induces titers and a profile very similar to NP-␣GalCer alone (IgM Ͼ IgG2c Ͼ IgG3 Ͼ IgG2b, IgG1), whereas NP-KLH plus ␣GalCer (mixed, i.p.) induces high titers that have a mixed profile similar to both the protein in alum and the NP-␣GalCer immunization (IgG2c Ͼ IgG1 Ͼ IgM, IgG2b Ͼ IgG3) (Fig. S6) .
Costimulation Requirements for B Cell Help from iNK T Cells. Cognate T cell help for MHC/peptide presenting B cells requires costimulatory molecules on the B and T cells and T cell cytokines. In this model, B7-1/2
Ϫ/Ϫ mice immunized with NP-␣GalCer produced less IgG anti-NIP (4 g/ml) than similarly immunized WT mice (21 g/ml) by day 7 (Fig. 7A) . WT mice produce more IgG anti-NIP when immunized with NP-KLH/alum than B7-1/2 Ϫ/Ϫ mice, and neither mouse makes a response to PBS (Fig. 7A) . Also, CD40L
Ϫ/Ϫ , IL-4 Ϫ/Ϫ , and IFN␥ Ϫ/Ϫ mice were immunized in vivo with NP␣GalCer or NP-KLH/alum. By day 7, CD40L Ϫ/Ϫ mice produced less IgG anti-NIP than WTs after NP-␣GalCer (3 vs. 171 g/ml) or NP-KLH/alum (3 vs. 688 g/ml) immunization (Fig. 7 B and C) . IFN␥ Ϫ/Ϫ mice produced less IgG anti-NIP than B6 WT mice in response to NP-␣GalCer or NP-KLH/alum (Fig. 7 B and C) .
IL-4
Ϫ/Ϫ mice produced equal or slightly greater amounts of IgG anti-NIP than B6 WT mice (Fig. 7B ) and showed no changes in isotype ratios (Fig. S7A ) in response to NP-␣GalCer. In addition, adding CD40L-blocking antibody in vitro reduced NP-␣GalCer-treated B cell proliferation by 37% over isotype control but had no effect on the NK T cell response (Fig. S7B) . Thus, CD40L, B7-1/2, and IFN-␥, but not IL-4, are important for iNK T cell-mediated B cell help for NP-␣GalCer responses.
Discussion
T cell help for B cells is a key paradigm for facilitating proteinspecific antibody production, yet the mechanism of lipid-specific antibody production has remained uncharted. We used a model hapten lipid antigen very similar to the well established haptenatedprotein antigen used by many investigators to decipher the nature of CD4 ϩ T cell help for protein-specific B cells (18) . By measuring B cell responses against a CD1d-presented iNK T cell-restricted lipid ligand (␣GalCer) linked to the hapten NP, we determined the mechanisms of class-switched antigen-specific responses that require both BCR cross-linking by the hapten-bearing lipid antigen and T cell help provided by TCR-activated, CD1d-restricted iNK T cells. B and iNK TcR Tg T cell in vitro cultures proliferate only to immunogens such as NP-␣GalCer, which contain an iNK T cell activation component, and NP-␣GalCer-induced IgG and IgM depends on CD1d-restricted iNK T cells, not diverse NK T cells. This finding suggests that the B cell must receive both a B cell receptor cross-linking signal and a second signal from a helper iNK T cell to make proliferation and class-switched IgG antigen-specific responses. T-independent type II B cell antigens require polyvalency for their proliferative effect, but the stimulatory NP-␣GalCer in this system is monovalent.
B cells are 100-1,000 times more efficient at presenting antigen than professional APCs if the antigen is limiting and is specifically internalized via the B cell receptor (22) . Efficient B cell responses are facilitated by expression of costimulators on T cells recognizing the antigen presented by the B cell, known as cognate T cell help. Noncognate, or bystander help, requires higher doses of antigen, colocalization of an activated T cell, an APC, and the relevant B cell and is less likely to lead to prolonged memory B cell responses (23) . Our results suggest that presentation of lipid antigen by the same B cell that has had its BCR cross-linked recruits more effective cognate iNK T cell help.
Cognate T cell help for protein-specific B cells usually requires B and T cell costimulatory molecules such as CD40L/CD40 (24) and B7-1 ϩ 2/CD28 (25) in combination with T cell-secreted cytokines such as IFN-␥ and IL-4 (26). Our results suggest a model where CD1d-restricted iNK T cells provide cognate help for lipidpresenting B cells by way of CD40L and B7-1/2 costimulatory molecules in addition to IFN-␥ production (Fig. 8) . We also found that sorted MZ B cells stimulate more proliferation in response to NP-␣GalCer than FO B cells. NP-␣GalCer also stimulates predominantly IgM, IgG3, and IgG2c, which is consistent with an IgM, IgG3-dominant MZ B cell response. These results suggest that MZ B and iNK T cell cooperation may occur in the antibody response to certain lipid antigens, but more study is needed to confirm this interaction.
CD1d Ϫ/Ϫ mice make reduced levels of organism lysate-specific antibody during Plasmodium berghei and Borrelia hermsii infection (3, 4) , suggesting an important role for both iNK T cells and B cells in these infections. CD1d-binding lipid antigens purified from B. burgdorferi (6) may, like our model NP-␣GalCer lipid antigen, stimulate iNK T cells and at the same time contain B cell epitopes that could induce protective antibodies during infection. This mechanism may ultimately help predict which glycolipid antigens would be B cell immunogens. Few of these antigens have yet to be identified, suggesting there may even be some natural selection against them, as a form of immune evasion. Given the limited polymorphism of CD1, iNK T cells will be a higher-frequency provider of T cell help for antigens than any peptide-specific, haplotype-restricted T cell population, making CD1 an appealing system for vaccine development. These studies underscore the emerging role for CD1 and iNK T cells in the B cell responses that are important in infection, autoimmunity, and tumor immunity.
Materials and Methods
Lipids. For synthesis of nitrophenyl donor I, reagents and conditions were (i) SOCl 2, 50°C, 1 h; 6-aminohexanol, CH2Cl2, 3 h, and (ii) DMSO, Ac2O/AcOH, 2 d. For synthesis of ␣GalCer with nitrophenyl hapten, compound II was synthesized as described (27) ; activation of thiomethyl group of compound I with benzensulfinylpiperidine (BSP)/trifluoromethanesulfonic anhydride (Tf 2O) was as described (28) ; Ce(OTf) 3, MeNO2/H2O; NaOMe/MeOH. For synthesis of ␤GalCer with nitrophenyl hapten, compound III was synthesized as described (29), and compound IV was synthesized as described (27) . Glycosylation reaction was performed with BSP/Tf2O, as described (28); NaOMe/MeOH; H2S/Py, room temperature (r. Statistics. Significant differences assessed by two-tailed Student's t tests or ANOVA tests with post hoc group comparisons using EXCEL or PRISM software. P Յ 0.05 is considered significantly different.
